Back to search
Non-syndromic Retinitis Pigmentosa
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-syndromic Retinitis Pigmentosa trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-syndromic Retinitis Pigmentosa trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A phase I/II dose-escalating study of the safety, tolerability and efficacy of KIO-301 administered intravitreally to patients with retinitis pigmentosa and cho…
The objective of this study is to evaluate the safety and tolerability of escalating doses of a gene therapy called GS030-DP (injected study treatment) administ…